secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0001628908-23-000162
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Q3 revenue $511M (+45% YoY), adjusted EBITDA $48.7M, raises 2023 guidance
--------------------------------------------------------------------------------

- Revenue $511.0M, up 44.9% YoY; net loss $33.2M (6.5% margin); adjusted EBITDA $48.7M (9.5% margin).
- Specialty care revenue grew 80% vs prior year; NIA acquisition contributed ~24% of growth.
- Added three new operating partnerships in Q3; total YTD nine vs annual target of six to eight.
- Raised mid-point of 2023 revenue and Adjusted EBITDA outlook; confident in $300M run rate by end of 2024.
- Total Lives on Platform 78.1M (up from 19.5M YoY); unique members 41.7M (up from 16.6M).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000162/0001628908-23-000162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000162/evh-20231102.htm
  HTML page:      https://secwatch.observer/filing/0001628908-23-000162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer